Armando Anido
Director/Board Member at SCYNEXIS, INC.
Net worth: 36 750 $ as of 30/09/2023
Profile
Armando Anido is an Independent Director at SCYNEXIS, Inc. and a Director at Auris Medical AG.
He is also the President of Malvern Consulting Group, Inc. Previously, he served as the President, Chief Executive Officer & Director of Auxilium Pharmaceuticals LLC from 2006 to 2011.
From 2012 to 2014, he was the Chief Executive Officer & Director of NuPathe, Inc. He also served as the Chairman & Chief Executive Officer of Zynerba Pharmaceuticals, Inc. from 2014 to 2023.
Additionally, he was an Independent Director at Adolor Corp.
from 2003 to 2011.
Mr. Anido has a background in sales and marketing, having worked as the Executive Vice President-Sales & Marketing at MedImmune LLC from 1999 to 2006 and as the Vice President-Central Nervous System Marketing at Glaxo Wellcome, Inc. from 1995 to 1999.
He also held the position of Vice President-AntiInfectives at Lederle Laboratories from 1989 to 1995.
Mr. Anido holds an undergraduate degree and an MBA from West Virginia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCYNEXIS, INC.
0.07% | 15/06/2023 | 25,000 ( 0.07% ) | 36 750 $ | 31/03/2024 |
| 10/10/2023 | 0 ( -.--% ) | - $ | 30/09/2023 |
Armando Anido active positions
| Companies | Position | Start |
|---|---|---|
| SCYNEXIS, INC. | Director/Board Member | 21/01/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Director/Board Member | 01/04/2016 |
Malvern Consulting Group, Inc.
 Malvern Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA. | President | - |
Former positions of Armando Anido
| Companies | Position | End |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Chief Executive Officer | 10/10/2023 |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Director/Board Member | 01/03/2018 |
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Director/Board Member | 01/09/2014 |
| NUPATHE INC | Chief Executive Officer | 01/03/2014 |
| AUXILIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 07/12/2011 |
Training of Armando Anido
| West Virginia University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Private companies | 12 |
|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
| Glaxo Wellcome, Inc. | Health Technology |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a private company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
Malvern Consulting Group, Inc.
Malvern Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA. | Commercial Services |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Armando Anido
